Benitec Biopharma Inc. (BNTC) NASDAQ
10.58
-0.24(-2.22%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
10.58
-0.24(-2.22%)
Currency In USD
Address
3940 Trust Way
Hayward, CA 94545
United States of America (the)
Phone
510 780 0819
Website
Sector
Healthcare
Industry
Biotechnology
Employees
16
First IPO Date
June 24, 2014
| Name | Title | Pay | Year Born |
| Jerel A. Banks | Executive Chairman & Chief Executive Officer | 1.07M | 1976 |
| Michael Graham | Head of Discovery & Founding Scientist | 139,036 | N/A |
| Megan Joan Boston | Chief Financial Officer, Secretary & Director | 870,813 | 1973 |
| Sophie Mukadam | Chief Operating Officer | 940,439 | 1981 |
| Claudia Kloth | Senior Vice President of Manufacturing | 0 | N/A |
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.